SCHEMBL5497835

SCHEMBL5497835

C=CC[Si](Cl)(CCl)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168085 0.83
SCHEMBL2167757 0.73
SCHEMBL15302844 0.73 TSHR (0.32)
SCHEMBL253633 0.71
SCHEMBL6046412 0.71
SCHEMBL231601 0.69
SCHEMBL27574 0.69
SCHEMBL6063988 0.69 TSHR (0.35)
SCHEMBL15302560 0.69 TSHR (0.35)
SCHEMBL1493194 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7297343-B2 Bioactive medical films BIOSURFACE ENGINEERING TECHNOLOGIES, INC. (US) 2007-11-20 US disclosed
EP-1311551-A4 BIOACTIVE COATING COMPOSITIONS AND METHODS BIOSURFACE ENG TECH INC (US) 2007-04-18 EP disclosed
US-6921811-B2 Bioactive coating composition and methods BIOSURFACE ENGINEERING TECHNOLOGIES, INC. (US) 2005-07-26 US disclosed
US-20040161442-A1 Bioactive coating composition and methods BIOSURFACE ENGINEERING TECHNOLOGIES, INC. 2004-08-19 US disclosed
US-20040151764-A1 Bioactive medical films BIOSURFACE ENGINEERING TECHNOLOGIES, INC. (US) 2004-08-05 US disclosed
EP-1159302-B1 NON-THROMBOGENIC SILYL MODIFIED HEPARIN COATING COMPOSITION AND METHODS FOR USING SAME INNERDYNE MEDICAL INC (US) 2004-03-31 EP disclosed
US-6630580-B2 Silyl heparin complex for use in attaching cells to prostheses, including vascular grafts and bone grafts INNERDYNE, INC. 2003-10-07 US disclosed
US-6596699-B2 Polyanion substrate having bound thereto by non-covalent means a condensate comprising a polycation and nucleic acid; for contacting surfaces of medical devices BIOSURFACE ENGINEERING TECHNOLOGIES, INC. 2003-07-22 US disclosed
EP-1311551-A1 BIOACTIVE COATING COMPOSITIONS AND METHODS Biosurface Engineering Technologies, Inc. (US) 2003-05-21 EP disclosed
US-20020160098-A1 Nucleic acid coating compositions and methods BIOSURFACE ENGINEERING TECHNOLOGIES, INC. 2002-10-31 US disclosed
US-20020115836-A1 Non-thrombogenic coating composition and methods for using same BIOSURFACE ENGINEERING TECHNOLOGIES, INC. 2002-08-22 US disclosed
WO-2002010221-A1 BIOACTIVE COATING COMPOSITIONS AND METHODS BIOSURFACE ENGINEERING TECHNOLOGIES, INC. (US) 2002-02-07 WO disclosed
US-6342591-B1 Amphipathic coating for modulating cellular adhesion composition and methods BIOSURFACE ENGINEERING TECHNOLOGIES, INC. 2002-01-29 US disclosed
US-5955588-A COVALENT COMPLEX OF 1 TO 30 HYDROPHOBIC SILYL MOIETIES DIRECTLY BOUND TO SODIUM HEPARIN VIA COVALENT BONDING; STABLE ANTICOAGULANT ACTIVITY OVER TIME; COST-EFFECTIVE PRODUCTION; FOR USE IN MEDICAL DEVICES INNERDYNE, INC. (US) 1999-09-21 US disclosed
US-4496551-A Fungicidal imidazole derivatives E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-01-29 US disclosed